Universal Health Services (UHS) has planned its Q4 2024 Earnings Release for February 26. In the interim, a UHS director made a significant stock sale of $308,515, leading to an increased monitoring of company's stocks. Additionally, the company is bracing for a hit due to a $535M judgment against its subsidiary, which it intends to appeal. In other developments, UHS has been scheduled to present at the 2024 Wolfe Research Healthcare Conference. Despite facing lawsuits and internal setbacks such as CEO transition and alleged abuse, the stock forecast and price predictions for 2025 remain promising. The company reported a $67 million loss after an apparent ransomware attack, which has since affected its overall returns. With this, the UHS stock has been in close comparison with HCA Healthcare to determine the better investment. Despite such hurdles, UHS continues its expansion endeavours including new residency programs, fellowships and hospital constructions. Nevertheless, the mounting allegations and settlements point towards a phase of scrutiny and possible operational restructuring for UHS.
Universal Health Services Class B UHS News Analytics from Wed, 07 Dec 2016 08:00:00 GMT to Wed, 22 Jan 2025 21:30:00 GMT - Rating -1 - Innovation -5 - Information 6 - Rumor -2
